AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Noninvasive breast fluid tests aim to detect disease at most treatable stage.
2004 OCT 7 - (NewsRx.com & NewsRx.net) -- Two companies are participating in the race to develop a screening technique for early-stage breast cancer based on testing breast fluid.
IMI International Medical Innovations, Toronto, Canada, has developed a breast cancer test that identifies a cancer-associated sugar in a sample of nipple aspirate fluid derived from the breast ducts and painlessly expressed through the nipple using a pump.
"Most breast cancers originate in the breast ducts, so nipple aspirate fluid is a logical sample to target," said Anees Chagpar, an assistant professor in the Division of Surgical Oncology, University of Louisville, USA. "The early results we have seen with this test are promising, and we are planning additional studies to confirm and expand our findings."
IMI's test is cost effective relative to other current screening options, the company claims.
The same sugar marker is being used by IMI in new tests for colorectal and lung cancers, which examine rectal mucus and sputum, respectively. In each test, the sample is treated with a series of chemicals that cause a color-change reaction. The color change is measured by a spectrophotometer, producing a quantified test result.
Power3 Medical Products, Inc. (OTCBB: PWRM), in the meantime, received notice that the ...
- Two drinks a day increases risk of breast cancer, study shows.
- Magazine article from: Women's Health Weekly March 4, 2004 700+ words
...MD, founder of The Breast Cancer Care & Research...or hopeful time for breast cancer research and treatment...for their particular breast cancer." This article was prepared by Women's Health Weekly editors from staff...
- Irsogladine side-steps angiogenic function to stop breast cancer metastasis.
- Magazine article from: Women's Health Weekly March 25, 2004 700+ words
...agent, irsogladine. Breast Cancer Res Treat, 2004...publisher of the journal Breast Cancer Research and Treatment...Gastroenterology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Change on enzyme gene may associate with invasive disease.(breast cancer...
- Magazine article from: Women's Health Weekly January 9, 2003 700+ words
...than women without breast cancer carried a polymorphism...MMP-3 * Women whose breast cancer had spread were more...metastasis in women with breast cancer This article was prepared by Women's Health Weekly editors from staff...
- Protein tyrosine phosphatase gamma is a tumor suppressor gene in breast cancer.
- Magazine article from: Women's Health Weekly April 1, 2004 700+ words
...independent growth of breast cancer cells in soft agar...PTP gamma) in human breast cancer cell line MCF-7...Enzymology, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- HCCR-2 related to breast cancer development and p53 tumor suppressor regulation.
- Magazine article from: Women's Health Weekly May 6, 2004 700+ words
...Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR...Biotechnology, Oncogenesis and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff and other...
- Older breast cancer patients in Canada benefit from early detection.
- Magazine article from: Women's Health Weekly June 24, 2004 700+ words
...year survival of 2192 breast cancer women diagnosed between...Survival of women with breast cancer in Ottawa, Canada...amp; Mortality, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Gene patterns in the ERBB2/TOP2A region of breast cancer influence outcomes.
- Magazine article from: Women's Health Weekly June 17, 2004 700+ words
...ERBB2/TOP2A region of breast cancer influence outcomes...ERBB2/TOP2A region in breast cancer. Gene Chromosome Cancer...Oncogenesis, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- Cystatin M is a novel candidate tumor suppressor gene for breast cancer.
- Magazine article from: Women's Health Weekly December 30, 2004 700+ words
...suppressor gene for breast cancer," Zhang concluded...suppressor gene for breast cancer. Cancer Res, 2004...Suppressor Gene and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- PTEN gene inactivation associates with breast cancer dissemination.
- Magazine article from: Women's Health Weekly February 12, 2004 700+ words
...and progression of breast cancer may not be explained...not angiogenesis, of breast cancer. Pathol Int, 2004...Proteomics, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
- COX-2-derived prostaglandin E-2 is a potent breast cancer stimulant.
- Magazine article from: Women's Health Weekly March 11, 2004 700+ words
...prostaglandin E-2 is a potent breast cancer stimulant. "Overexpression...cyclooxygenase 2-induced breast cancer progression. Proc...Enzymology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Source: HighBeam Research, Noninvasive breast fluid tests aim to detect disease at most...